While the world obsesses over AI and crypto, a 27-person Estonian biotech is engineering the future of fats. ÄIO isn't just making alternatives—they're rewriting the molecular blueprint of what we eat, replacing palm oil and animal fats with precision fermentation.

"This isn't another plant-based meat startup. They're attacking the $80B fat market from the molecular level, and the incumbents haven't even noticed yet."

• Precision fermentation replaces palm oil at the molecular level, not just functionally
• €7.68M funding for 27 employees = €284K per person—efficient capital deployment
• Direct traffic (58%) suggests B2B partnerships, not consumer marketing
• Estonian biotech ecosystem advantage: EU funding + technical talent

The real opportunity here is the market timing. With the EU cracking down on palm oil imports and consumer backlash against animal fats, ÄIO is positioned at the intersection of regulatory pressure and technological readiness. Their $4.2M revenue on $7.68M funding suggests they're already generating commercial traction—rare for a biotech at this stage.